Premarket Alert: Novavax active for a second session (NVAX)

Posted in General 
July 1st, 2009

Shares of vaccine maker Novavax Inc. (Nasdaq: NVAX) are rising in premarket trading, seeing some continued buying a day after Spanish health authorities licensed its technologies to make pandemic and seasonal flu vaccines.

The stock had risen more than 30 percent yesterday on the news.

Boutique research firm Rodman and Renshaw raised its target on Novavax shares to $5 from $4 this morning, suggesting Spain is providing additional validation fo the company’s technology and it may be a foothold for Novavax to register its vaccine in other countries.

Comments are closed